NCT04677985

Brief Summary

Background: Both health professionals and consumers use menthol-based topical analgesics extensively for the temporary relief of pain from musculoskeletal ailments or injury. However, there are no reports of differences in the pain pressure threshold (PPT) or the relative effectiveness of topical analgesics to reduce pain in the upper and lower body muscles and tendons. Objectives: The objective of this study was to investigate whether differences existed in PPT and relative pain attenuation associated with a menthol based topical analgesic over a variety of upper and lower body muscles and tendons. Design: Randomized allocation, controlled, intervention study. Method: Sixteen participants (10 females and 6 males), who were tested on their dominant or non-dominant side. The order of specific muscle / tendon testing was also randomized, which included upper body (middle deltoid, biceps brachii, and lateral epicondylar tendon) and lower body locations (quadriceps, hamstrings, gastrocnemius, lumbo-sacral erector spinae muscles, and patellar and Achilles tendons). PPT was monitored before and 15-minutes following the application of a menthol based topical analgesic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 21, 2020

Completed
Last Updated

December 21, 2020

Status Verified

December 1, 2020

Enrollment Period

6 months

First QC Date

December 14, 2020

Last Update Submit

December 18, 2020

Conditions

Keywords

mentholmusculoskeletaltendonslower back

Outcome Measures

Primary Outcomes (1)

  • Pain pressure threshold

    Measures the force applied to the muscle or tendon till pain is detected.

    Applied 15 minutes after application of topical analgesic or placebo.

Study Arms (2)

Menthol based topical analgesic

EXPERIMENTAL

Menthol based topical analgesic was applied to a variety of upper and lower body muscles and tendons.

Combination Product: Menthol based topical analgesic

Placebo

PLACEBO COMPARATOR

Placebo (cream that smelled like menthol) was applied to a variety of upper and lower body muscles and tendons.

Combination Product: Menthol based topical analgesic

Interventions

Topical analgesic or placebo was applied to upper and lower body muscles and tendons and pain pressure threshold was measured with a handheld algometer.

Also known as: Menthol smelling cream with no analgesic
Menthol based topical analgesicPlacebo

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \. Healthy individuals with no musculoskeletal or neural pathologies.

You may not qualify if:

  • \. Musculoskeletal or neural pathologies / injuries in the year before the experiment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial University of Newfoundland

St. John's, Newfoundland and Labrador, A1C 5S7, Canada

Location

MeSH Terms

Conditions

Acute PainMyalgiaTendon Injuries

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesMusculoskeletal PainWounds and Injuries

Study Officials

  • David G Behm, PhD

    Memorial University of Newfoundland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Placebo and analgesic applications were identified by numbers which were only revealed after the statistical analysis.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Random allocation of the application of a menthol based topical analgesic versus a placebo.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
University Research Professor

Study Record Dates

First Submitted

December 14, 2020

First Posted

December 21, 2020

Study Start

May 1, 2019

Primary Completion

October 30, 2019

Study Completion

December 31, 2019

Last Updated

December 21, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will share

Excel sheet data can be obtained upon request.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
December 14, 2020 onwards

Locations